Only a few studies investigated the effects of CTLA4 blockade on breast cancer, most of which combined CTLA4 blocking drugs with other treatments such as aromatase inhibitors, radiotherapy, and chemotherapy. The gene discussed is CYP19A1; the disease is breast cancer.